Elevance Health Inc. (ELV) — Insider Activity & Signal

Healthcare · Medical - Healthcare Plans · Market cap $81.6B · $376.40 · 52-week range $273.71–$436.24

Recent insider buying

Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.

Date	Insider	Role	Shares	Price	Value	Source
2026-07-17	PERU RAMIRO G	director	1,000	$366.05	$366,050	SEC Form 4
2026-07-17	BOUDREAUX GAIL	director, officer: President and CEO	2,045	$368.25	$753,071	SEC Form 4
2026-07-17	BOUDREAUX GAIL	director, officer: President and CEO	680	$366.41	$249,159	SEC Form 4
2026-03-05	COLLIS STEVEN H	director	3,000	$289.84	$869,520	SEC Form 4

Financial health

Altman Z-Score 2.61 · Piotroski F-Score 8/9 · Cash $9.5B · Debt $33.2B

ClearOcean signal read

ClearOcean's model currently scores ELV as a watchlist-level signal (7/10), based on the insider, fundamental and risk data above. This is a factual model output, not advice.

Sources & further reading

Primary filings: SEC EDGAR — ELV Form 4
How ClearOcean reads insider activity

Last updated July 31, 2026.

ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.